These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53 related articles for article (PubMed ID: 2791867)
1. [Isolation of a recombinant strain of vaccinia virus containing the pre S2 region of the viral hepatis B surface antigen in its virion]. Loparev VN; Mitina IV; Araslanov RR; Ivanova ON; Cheliapov NV; Lotte VD; Chernos VI Dokl Akad Nauk SSSR; 1989; 306(5):1250-2. PubMed ID: 2791867 [No Abstract] [Full Text] [Related]
2. [Isolation of a recombinant vaccinia virus based on the LIVP strain inducing the surface antigen of the hepatitis B virus]. Al'tshteĭn AD; Zakharova LG; Loparev VN; Pashvykina GV; Gorodetskiĭ SI Dokl Akad Nauk SSSR; 1985; 285(3):696-9. PubMed ID: 4092585 [No Abstract] [Full Text] [Related]
3. [Synthesis of the E-antigen of the hepatitis B virus (HBeAg) in eukaryotic cells by a recombinant strain of the vaccinia virus]. Loparev VN; Araslanov RR; Mitina IV; Chernos VI Mol Gen Mikrobiol Virusol; 1991 Sep; (9):3-6. PubMed ID: 1745274 [TBL] [Abstract][Full Text] [Related]
4. Antigenic properties of vaccinia virus and of the virus recombinant strains expressing heterologous genes. Chelyapov NV; Antonova TP; Yanova NN; Chernos VI Acta Virol; 1988 Sep; 32(5):409-16. PubMed ID: 2904735 [TBL] [Abstract][Full Text] [Related]
5. Characterization of complex B cell epitopes on woodchuck hepatitis virus surface antigens by using plasmids encoding chimeric proteins and DNA immunization. Zheng X; Schirmbeck R; Hilken G; Waters JA; Yang D; Reimann J; Roggendorf M; Lu M Virology; 2002 Mar; 294(2):342-53. PubMed ID: 12009876 [TBL] [Abstract][Full Text] [Related]
6. [Double recombinants of the vaccinia virus expressing hepatitis B virus surface antigen and herpes simplex virus thymidine kinase]. Al'tshteĭn AD; Andzhaparidze OG; Antonova TP; Baev AA; Baĭsar D Dokl Akad Nauk SSSR; 1986; 289(6):1493-6. PubMed ID: 3021422 [No Abstract] [Full Text] [Related]
7. Identification of vaccinia promoters by heterologous expression of hepatitis B surface antigen in mouse cells infected by recombinant vaccinia viruses. Barbeyron T; Mars M; Schroeder E; Malpièce Y; Plucienniczak A; Beaud G; Streeck RE Biochim Biophys Acta; 1987 Dec; 910(3):240-4. PubMed ID: 3676323 [TBL] [Abstract][Full Text] [Related]
8. Point mutations in the S and pre-S2 genes observed in two hepatitis B virus carriers positive for antibody to hepatitis B surface antigen. Shinji T; Koide N; Hanafusa T; Hada H; Oka T; Takayama N; Shiraha H; Nakamura M; Ujike K; Yumoto Y; Tsuji T Hepatogastroenterology; 1998; 45(20):500-2. PubMed ID: 9638436 [TBL] [Abstract][Full Text] [Related]
9. Infectious hepatitis B virus variant defective in pre-S2 protein expression in a chronic carrier. Fernholz D; Galle PR; Stemler M; Brunetto M; Bonino F; Will H Virology; 1993 May; 194(1):137-48. PubMed ID: 8480417 [TBL] [Abstract][Full Text] [Related]
10. [Effective method of introducing plasmid DNA into eukaryotic cells by using liposomes for producing vaccinia virus recombinants]. Slepushkin VA; Bukrinskiĭ MI Biull Eksp Biol Med; 1987 Oct; 104(10):478-80. PubMed ID: 2823928 [TBL] [Abstract][Full Text] [Related]
11. Properties of hepatitis B virus pre-S1 deletion mutants. Melegari M; Bruno S; Wands JR Virology; 1994 Mar; 199(2):292-300. PubMed ID: 8122362 [TBL] [Abstract][Full Text] [Related]
12. [Cloning and expression of the gene coding the hepatitis B virus surface antigen (HBsAg) in Escherichia coli]. Lunin VG; Gol'dberg EZ; Grigor'ev VG; Mikhaĭlov MM; Khudiakov IuE Dokl Akad Nauk SSSR; 1983; 268(2):496-8. PubMed ID: 6339184 [No Abstract] [Full Text] [Related]
13. [Gene expression of the surface antigen of the hepatitis B virus in yeast cells]. Granovskiĭ NN; Zhdanov VM; Arman IP; Legchilina SP; Vasilenko SK Mol Gen Mikrobiol Virusol; 1986 Aug; (8):12-9. PubMed ID: 3537767 [No Abstract] [Full Text] [Related]
14. [The comparative mapping of virion and cloned DNA of the hepatitis B virus]. Pumpen PP; Kozlovskaia TM; Dishler AV; Bychko VV; Kalis IaV Mol Biol (Mosk); 1982; 16(6):1314-21. PubMed ID: 6296666 [TBL] [Abstract][Full Text] [Related]
15. A new genetically engineered vaccine for animal growth promotion. Xu WZ; Du NX; Li GD; Wang Y; Li ZP Sci China B; 1994 Oct; 37(10):1234-41. PubMed ID: 7865123 [TBL] [Abstract][Full Text] [Related]
17. [Synthesis and expression of the DNA fragment coding the antigenic determinant of the surface antigen protein of hepatitis B virus]. Smirnov VD; Sergienko OV; Skripkin EA; Dubichev AG; Lunin VG Bioorg Khim; 1983 Oct; 9(10):1388-94. PubMed ID: 6207838 [TBL] [Abstract][Full Text] [Related]
18. Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen. Smith GL; Mackett M; Moss B Nature; 1983 Apr; 302(5908):490-5. PubMed ID: 6835382 [TBL] [Abstract][Full Text] [Related]
19. Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus. Parkinson JE; Smith GL Virology; 1994 Oct; 204(1):376-90. PubMed ID: 8091668 [TBL] [Abstract][Full Text] [Related]
20. Hemagglutination assay of polypeptide coded by the pre-S region of hepatitis B virus DNA with monoclonal antibody: correlation of pre-S polypeptide with the receptor for polymerized human serum albumin in serums containing hepatitis B antigens. Okamoto H; Imai M; Usuda S; Tanaka E; Tachibana K; Mishiro S; Machida A; Nakamura T; Miyakawa Y; Mayumi M J Immunol; 1985 Feb; 134(2):1212-6. PubMed ID: 2981263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]